Español · Català · English
"It is so amazing that we don’t need to analyze the amniotic fluid to determine the fetal lung maturity.
We believe that it will become an essential tool for any center dedicated to the Fetal Medicine"

Dr. Guillermo Azumendi Perez, Centro Gutenberg
 
“One of the major challenges in the modern obstetrics has been to determine the Fetal Lung Maturity. But traditional methods based on amniocentesis have the limitation for being invasive and having the risk to cause premature rupture of membranes and preterm labor. quantusFLM is the solution to this clinical dilemma since it fulfills three fundamental criteria: Is 100% Non-Invasive, has similar sensitivity and specificity to those invasive tests, and can be performed by any physician and used in any case in which Fetal Lung Maturity needs to be determined.”
 
Rogelio Cruz Martínez M.D, PhD, Medicina Fetal México, México
 
“According to the present protocol, after 35 weeks of pregnancy, we do not take any measure to accelerate the fetal lung maturation. However, it is widely recognized that the risk of Neonatal Respiratory Morbidity (NRM) still exists even after that gestational age. At the same time,elective caesarean sections will also increase the risk of NRM. For that reason, we believe that in the case where the birth decision critically depends on the maturity of fetus´ lungs, quantusFLM will certainly help obstetricians to determine the perfect timing for delivery.”
 
Dra. M. Dolores Gómez, Director of Institute Dra. Gómez Roig, Spain
 
“In our center, we consider quantusFLM a really helpful tool. It is a non-invasive, fast, safe and reliable test that help us make clinical decisions with more relevant information so we can avoid situations in which the health of the newborn baby could be at risk.”


 
 
Dr José Enrique Sanín Blair, Medicina Fetal S.A, Colombia
 
“We have recently begun using quantusFLM to study the fetal lung maturity in some of our patients and the experience, by far, is very positive. We believe that under certain circumstances, it is very interesting to know the level of the lung maturity, which is often a determing factor on choosing the timing to terminate the pregnancy. For us it is very easy to use quantusFLM because it requires a very standard image acquisition process and the turnaround of the results is incredible fast ( we usually have the results within minutes.) It is so amazing that we don’t need to analyze the amniotic fluid to determine the fetal lung maturity. We believe that It will become an essential tool for any center dedicated to the Fetal Medicine.”
 
Dr.Guillermo Azumendi Perez,Centro Gutenberg,Spain
 
“Incorporating the lung texture analysis into the diagnostic arsenals of predicting Neonatal Respiratory Morbidity has represented a big step forward on the prenatal diagnosis of the fetal lung maturity. Despite being like all new tests, in the beginning, that can receive little skepticism from other professionals, the advantages of this technology, being no-invasive, easy to use, fast and reliable results as well as at a reasonable cost, have won the trust of those professionals and the appreciation from patients. We are sure that quantusFLM is a test that is going to stay and is a good example of how the results of the clinical research can transfer into a daily clinical tool with such innovative solutions to diagnosing the common problems.”
 
MD, PHD Miguel Parra-Saavedra, CEDIUL, Colombia
 
“quantusFLM is a study that has brought us the security in managing the preterm deliveries for our patients because with this test, which is not only non-invasive but also has strong evidences, we can have the results in less than 2 minutes. Moreover, quantusFLM is at a relatively lower cost that those invasive tests. Thanks Transmural Biotech for giving us such a simple tool.”

 

 
Dr. Marco A. Velasco Herrera, URA, Mexico
 
“As there are fewer and fewer interventionists in the field of obstetrics, a non-invasive test like quantusFLM certainly presents a breakthrough that can contribute greatly to the better management of the planned deliveries.”

 

 

 
Dr. Carles Catlla, Chief of Obstetrics and Gynecology, Institute Marquès, Spain
 
“quantusFLM has assured me of a fast, reliable and safe fetal lung maturity test with very professional and timely advice.”



 

 
Dr. Joaquin Bustillos, MD MS, Maternal Fetal Medicine, Costa Rica
 
“We think that developing a non-invasive solution to determine the fetal lung maturity will have great impact in the decision-making process when those decisions are about the well-being of the mother and baby as well as the society in general. We have very nice experiences with using quantusFLM and are very satisfied with the results. We strongly recommend quantusFLM without any doubt!”
 
 
 
Dr. Luciano Gutiérrez, Centro Vida La Paz, Bolivia
 
“There is no doubt that quantusFLM has allowed us to stop using the traditional invasive method to determine the fetal lung maturity. quantusFLM is not only reliable but also has zero complications to the fetus and the mothers.”
 
 
 
 
 
Dr. Pablo Parra Ramírez, Medicina Materno Fetal, Costa Rica
 
“From a long time ago we, as Obstetrician & Gynecology specialists, have needed a noninvasive and reliable diagnostic tool to determine Fetal Lung Maturity. Recently I have witnessed quantusFLM usefulness with really satisfactory results that have helped me to take critical decisions to manage my pregnant patients.”
 
 
 
 
Dr. Daniel Kavanagh Suarez, Obstetrician & Gynecologist, México
 
“It is a truly amazing experience to have the certainty and the result in just 2 minutes. quantusFLM has allowed us to improve our results. When we give a patient the report with a high risk result, the patient understands why it is worthy to continue with the pregnancy, if possible. In the meanwhile, we can better understand the need to attend the delivery at a highly specialized center. In our case, as we are at the border, the majority of the babies are born in the United States where the cost of neonatal care is much higher than in Mexico. It is no doubt that knowing the risk of a newborn having difficulty with breathing will help the family evaluate the options properly.”
 
Dr. Hector Meza, Obstetrician & Gynecologist, México
 
“It is a tangible proof that an ultrasound in a skilled hands can change the course of a fetus especially when we have to deal with the concern of the respiratory distress every day in the obstetric practice. quantusFLM represents a revolutionary and reproducible method and maintains a high standard of to ensure that its final result gives us a peace of mind as an non-invasive test should do with its reliability very similar to those old tests. quantusFLM is an advanced fetal medicine as well as an additional tool for those who understand that the FETUS is actually a patient as well.”
 
 
Dr. Hugo Pineda, Obstetrician & Gynecologist, México
 
“As Neonatal Respiratory Morbidity is still the major problem for the premature babies despite prenatal and postnatal treatments available nowadays, this situation has presented an unsolved clinical need. A non-invasive fetal lung maturity test by just analyzing an ultrasound image of the fetal lungs has given us a great opportunity to avoid using any invasive test, like amniocentesis, to predict the neonatal respiratory distress risk when there is a need of delivering a baby before his due day, and with the same effectiveness as the amniocentesis.”
 
 
Dra. Paola Tucci Branco, Centro de Diagnóstico Enrique Rossi, Argentina
 
"In our center 99% are pregnant women, of which 13% are required to determine lung maturity before week 34. We have found in quantusFLM a quick test, and above all decisive, since in high risk fetuses, allows us to manage a 2nd maturity scheme, which allows us to bring to the world the fetus in the best conditions."
 
 
 
 
Dr. Edgar Flores, Maternal Fetal Medicine, Prenatal Care Institute, Mexico
 
“We have recently begun using quantusFLM to study the fetal lung maturity in some of our patients and the experience, by far, is very positive. It is a non-invasive, fast, safe and reliable test that help us make clinical decisions. Thanks Transmural Biotech for giving us such a simple and at the same time a reliable tool.”
 
 
 
 
Dr. Marek Šois, Obstetrician & Gynecologist, Loote Ultraheliskriining, Estonia
 

“Predict respiratory morbidity risk have been difficult for a long time using invasive methods. Nowadays quantusflm with a non-invasive and fast technique, lets us to know fetal lung maturity based on respiratory morbidity risk with a high reliability, that helps to end labor in the correct moment” 

 

 

 

 

Dr. Josué Zapata, Dr. Héctor Sosa, Fundación de Medicina Fetal Perú, ECOIMAGEN. Perú

 
 
 
Barcelona
Spain
Barcelona
Spain
Querétaro
Mexico
Muar, Johor
Malasya
San José
Costa Rica
Barranquilla
Colombia
Barcelona
Spain
Sonora
Mexico
San Luis
Mexico
Barcelona
Spain
Tel Hashomer
Israel
Barcelona
Spain
Itajaí
Brazil
Malaga
Spain
Barcelona
Spain
Managua
Nicaragua
Madrid
Spain
La Paz
Bolivia
Florianópolis
Brazil
Reus
Spain
Querétaro
Mexico
Tabasco
Mexico
Mérida
Mexico
Sant Cugat
Spain
Manizales
Colombia
Terrassa
Spain
Juárez
Mexico
Zamora
Mexico
Brasília
Brazil
Florianópolis
Brazil
San Ramón
Costa Rica
Fribourg
Switzerland
Chihuahua
Mexico
Ciudad del Río
Colombia
Lima
Peru
Cayma Arequipa
Peru
Aracaju
Brazil
Córdoba
Argentina
Noida
India
Guayaquil
Ecuador
Curitiba
Brazil
Xalapa
Mexico
Porto Alegre
Brazil
Monterrey
Mexico
Santiago
Argentina
México D. F.
Mexico
San José
Costa Rica
Lima
Peru
Región de Coquimbo
Chile
Hermosillo
Mexico
Quito
Ecuador
Málaga
Spain
Chihuahua
Mexico
Tallinn
Estonia
México D. F.
México
Lima
Peru
Mazatlán
Mexico
Santo Domingo
Republica Dominicana
Tijuana
México
Medellin
Colombia
San Isidro
Argentina
Madrid
Spain
Santiago
Chile
Rincon de Romos
Mexico
Granollers
Spain
Imperatriz
Brasil
Madrid
Spain
Barcelona
Spain
 
 
Request free trial
 
Sitemap
© quantusFLM is the property of Transmural Biotech